Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05487196 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia

A Phase 2 study, sponsored by Grace Lim, MD, MS.

Completed
Registry status
Phase 2
Development phase
88
Enrollment target

NCT05487196: Completed Phase 2 study, sponsored by Grace Lim, MD, MS.

NCT05487196 is a Phase 2 study that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 88 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05487196, a Phase 2 study, has completed, sponsored by Grace Lim, MD, MS.

COMPLETED
Registry status
Phase 2
Development phase
88 participants
Enrollment target

Study Summary

The purpose of this randomized controlled trial is to compare the effectiveness of epidural clonidine, dexmedetomidine, or fentanyl adjuncts for labor analgesia.

Primary Outcome

Pain score AREA UNDER THE CURVE (AUC), which is a calculated area under curve using the trapezoidal rule, where pain scores measured from 0 (no pain) to 10 (worst imaginable pain) are on the y axis, and time is on the x axis (pain scores were measured at 5 minutes, 10 minutes,15 minutes, 30 minutes after epidural initiation for the primary outcome assessment). The scale for AUC is not 0-10 but rather is completely dependent upon the area generated under the curve created by pain scores for the f

Interventions

  • DRUG Dexmedetomidine
  • DRUG Ropivacaine
  • DRUG Fentanyl
  • DRUG Clonidine

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2022-09-28
Est. Completion 2023-07-31
Phase Phase 2
Grace Lim, MD, MS

10 total trials

What the finished NCT05487196 record still lists

NCT05487196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower).

The record links to 0 conditions, and to 4 interventions - of which Dexmedetomidine is the first listed.

NCT05487196 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05487196 about?

NCT05487196 is a clinical study titled "Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia". The purpose of this randomized controlled trial is to compare the effectiveness of epidural clonidine, dexmedetomidine, or fentanyl adjuncts for labor analgesia.

What is the current status of trial NCT05487196?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2022-09-28. Estimated completion is 2023-07-31.

What interventions are being tested in trial NCT05487196?

The interventions under investigation include: Dexmedetomidine (DRUG), Ropivacaine (DRUG), Fentanyl (DRUG), Clonidine (DRUG).

Who is sponsoring clinical trial NCT05487196?

This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05487196's enrollment target sits among peer trials

88 803rd of 2000 higher than 1,191 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05487196, the US trial registry maintained by the National Library of Medicine. NCT05487196 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.